Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $6.80, but opened at $7.11. Ekso Bionics shares last traded at $6.90, with a volume of 21,765 shares changing hands.
Several research firms recently weighed in on EKSO. Zacks Investment Research downgraded shares of Ekso Bionics from a “buy” rating to a “hold” rating in a report on Thursday, June 18th. HC Wainwright restated a “buy” rating and issued a $12.00 price target (up previously from $8.00) on shares of Ekso Bionics in a research note on Friday. Aegis dropped their price target on shares of Ekso Bionics from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, May 21st. ValuEngine upgraded shares of Ekso Bionics from a “hold” rating to a “buy” rating in a research note on Thursday, April 2nd. Finally, Cantor Fitzgerald boosted their price target on shares of Ekso Bionics from $1.00 to $8.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 25th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Ekso Bionics presently has a consensus rating of “Buy” and an average price target of $9.25.
The company has a debt-to-equity ratio of 0.11, a current ratio of 1.86 and a quick ratio of 1.53. The business’s 50 day moving average is $4.01 and its 200 day moving average is $1.93. The stock has a market cap of $51.69 million, a price-to-earnings ratio of -4.15 and a beta of 2.02.
Ekso Bionics (NASDAQ:EKSO) last issued its earnings results on Thursday, April 30th. The company reported ($0.44) EPS for the quarter, topping analysts’ consensus estimates of ($0.61) by $0.17. The firm had revenue of $1.47 million during the quarter. Ekso Bionics had a negative net margin of 68.97% and a negative return on equity of 210.43%. As a group, analysts forecast that Ekso Bionics Holdings Inc will post -1.98 earnings per share for the current year.
Ekso Bionics Company Profile (NASDAQ:EKSO)
Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke.
Recommended Story: Catch-Up Contributions
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.